CD4 and myeloid sarcoma: The lack of colocalization evidence between MS and the cg14130459 cis-mQTL effect might be explained by the weaker mQTL association observed for cg14130459 in naïve CD4+ T cells of healthy participants (p = 0.006, BLUEPRINT study) in comparison to CD4+ T cells of MS patients (p = 2.68 × 10−10, our study).